Vogt-Koyanagi-Harada Disease Presenting as a Schizophrenia Spectrum Disorder: A Case Report

被引:0
|
作者
Kheradmand, Ali [1 ]
Safarzadeh, Hannaneh [2 ]
机构
[1] Shahid Beheshti Univ Med Sci, Dept Psychiat, Fac Med, Taleghani Hosp,Res Dev Comm, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Fac Med, Dept Psychiat, Tehran, Iran
关键词
Autoimmune; Psychosis; Schizophrenia; Vogt-Koyanagi-Harada;
D O I
10.5812/ijpbs-100423
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Introduction: Numerous autoimmune disorders accompany with psychosis. The Vogt-Koyanagi-Harada (VKH) disease is an autoimmune disease with no reports about its concomitance with psychosis so far. Case Presentation: We report the co-occurrence of schizophrenic spectrum diseases with VKH for the first time. They havecommon manifestations such as aggression, agitation, and self-talking, subsiding after chemotherapy. Workup evaluation was performed by computed tomography (CT) scan, magnetic resonance imaging (MRI), electroencephalography (EEG), lumbar puncture (LP) study, IQ test, lab tests for hepatitis and other infections, and retinal angiography and sonography. The patient underwent corticosteroid therapy, immunosuppressive therapy, risperidone, propranolol, and trihexyphenidyl. Conclusions: Our results showed the significant role of autoimmunity in the genesis of psychosis. On the other hand, unusual manifestations and slow response to treatment in these patients show that autoimmune disorders with psychosis may worsen the prognosis of psychosis.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Rituximab for sight-threatening refractory pediatric Vogt-Koyanagi-Harada disease
    Umran, Raid M. R.
    Shukur, Zaid Y. H.
    MODERN RHEUMATOLOGY, 2018, 28 (01) : 197 - 199
  • [42] Immunosuppressive therapy for Vogt-Koyanagi-Harada disease: a retrospective study and review of literature
    Najiha Rahman
    Jose Carlo M Artiaga
    Konstantinos Bouras
    Joshua Luis
    Angela Rees
    Mark Westcott
    Journal of Ophthalmic Inflammation and Infection, 13
  • [43] The Relationship of Vogt-Koyanagi-Harada Syndrome to Ocular Hypertension and Glaucoma
    Veerappan, Malini
    Fleischman, David
    Ulrich, J. Niklas
    Stinnett, Sandra S.
    Jaffe, Glenn J.
    Allingham, R. Rand
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2017, 25 (06) : 748 - 752
  • [44] The Incidence and Presentation Features of Glaucoma in Vogt-Koyanagi-Harada Syndrome
    Abdelaal, Abdelaziz
    Hassan, Abdul Rhman
    Katamesh, Basant E.
    Eltaras, Mennatullah Mohamed
    Serhan, Hashem Abu
    OPHTHALMOLOGY GLAUCOMA, 2024, 7 (06): : 587 - 601
  • [45] A Case of Vogt-Koyanagi-Harada Disease and Retinal Peri-Phlebitis in a Patient With Presumed Ocular Tuberculosis
    Amjad, Muhammad
    Zafar, Aruba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [46] Sensorineural hearing loss evolution in Vogt-Koyanagi-Harada syndrome
    Rodriguez Rivera, Vernica
    Perez Garrigues, Herminio
    Gallego Pinazo, Roberto
    ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2011, 62 (06): : 465 - 468
  • [47] Vogt-Koyanagi-Harada Syndrome in a Canadian First Nations Population
    Kryshtalskyj, Michael T.
    Roy, Mili
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (04) : 894 - 900
  • [48] Vogt-Koyanagi-Harada syndrome. About eight cases
    Alaoui, F. -Z.
    Benamour, S.
    El Kabli, H.
    Amraoui, A.
    REVUE DE MEDECINE INTERNE, 2007, 28 (04): : 250 - 254
  • [49] Infliximab therapy for 2 patients with Vogt-Koyanagi-Harada syndrome
    Wang, Yue
    Gaudio, Paul A.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2008, 16 (04) : 167 - 171
  • [50] MRI documented acute myelitis in a patient with Vogt-Koyanagi-Harada syndrome: First report
    Dahbour, Said S.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2009, 111 (02) : 200 - 202